Literature DB >> 17949416

Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages.

Ernesto Oviedo-Orta1, Alexandra Bermudez-Fajardo, Sharada Karanam, Ulrike Benbow, Andrew C Newby.   

Abstract

Metalloproteinases (MMPs) participate in extracellular matrix remodelling and regulatory signalling during chronic inflammatory states such as atherosclerosis formation. However, the sources and mediators of MMP upregulation need clarification. We investigated whether proinflammatory mouse T helper type 1 (Th1) lymphocytes are more active in MMP secretion than naïve Th0 or anti-inflammatory Th2 phenotypes, in the absence of specific antigenic stimulation, under baseline conditions and after contact with irradiated macrophages. We also compared the effect of Th0, Th1 or Th2 lymphocyte-conditioned medium and irradiated lymphocytes on MMP production from macrophages. Finally, we investigated whether CD40-CD40 ligand (CD40L) interactions were involved in T-cell-stimulated MMP secretion from macrophages. Under baseline conditions, MMP-2 messenger RNA (mRNA) and protein levels were greater in Th1 than Th0 or Th2 lymphocytes; MMP-9 mRNA, but not protein, was also upregulated. In the presence of irradiated macrophages MMP-2 and MMP-9 production from Th1 and Th2 was greater than from Th0 lymphocytes. Conditioned media from Th1 but not Th0 or Th2 cells increased MMP-9 secretion from macrophages. Irradiated Th1 lymphocytes stimulated both MMP-2 and MMP-9 secretion from macrophages more than irradiated Th2 or Th0 cells; this activation was independent of CD40-CD40L interaction. These findings demonstrate for the first time greater MMP secretion by Th1 than Th2 or Th0 lymphocytes and their greater ability to upregulate macrophage MMP secretion in the absence of specific antigenic stimulation. These mechanisms could promote matrix turnover in inflammatory states and, for example, promote atherosclerotic plaque rupture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949416      PMCID: PMC2434380          DOI: 10.1111/j.1365-2567.2007.02728.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

Review 1.  The pathophysiology of acute coronary syndromes.

Authors:  M J Davies
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

Review 2.  Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.

Authors:  Nicole L Webster; Suzanne M Crowe
Journal:  J Leukoc Biol       Date:  2006-09-07       Impact factor: 4.962

Review 3.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

4.  Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone.

Authors:  G Dew; G Murphy; H Stanton; R Vallon; P Angel; J J Reynolds; R M Hembry
Journal:  Cell Tissue Res       Date:  2000-03       Impact factor: 5.249

5.  Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.

Authors:  J Silence; F Lupu; D Collen; H R Lijnen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

Review 6.  Do metalloproteinases destabilize vulnerable atherosclerotic plaques?

Authors:  Andrew C Newby
Journal:  Curr Opin Lipidol       Date:  2006-10       Impact factor: 4.776

7.  Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations.

Authors:  E Oviedo-Orta; T Hoy; W H Evans
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

8.  Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice.

Authors:  X Zhou; A Nicoletti; R Elhage; G K Hansson
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

9.  Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.

Authors:  M Crisby; G Nordin-Fredriksson; P K Shah; J Yano; J Zhu; J Nilsson
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

10.  Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.

Authors:  V P Yakubenko; R R Lobb; E F Plow; T P Ugarova
Journal:  Exp Cell Res       Date:  2000-10-10       Impact factor: 3.905

View more
  26 in total

1.  MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.

Authors:  Latt Latt Aung; M Maral Mouradian; Suhayl Dhib-Jalbut; Konstantin E Balashov
Journal:  J Neuroimmunol       Date:  2014-11-10       Impact factor: 3.478

2.  Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells.

Authors:  Heather L Benson; Shahriar Mobashery; Mayland Chang; Farrah Kheradmand; Jeong Soo Hong; Gerald N Smith; Rebecca A Shilling; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-16       Impact factor: 6.914

3.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

4.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

5.  Hhip haploinsufficiency sensitizes mice to age-related emphysema.

Authors:  Taotao Lao; Zhiqiang Jiang; Jeong Yun; Weiliang Qiu; Feng Guo; Chunfang Huang; John Dominic Mancini; Kushagra Gupta; Maria E Laucho-Contreras; Zun Zar Chi Naing; Li Zhang; Mark A Perrella; Caroline A Owen; Edwin K Silverman; Xiaobo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-21       Impact factor: 11.205

6.  A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury.

Authors:  Laura E Edsberg; Jennifer T Wyffels; Rajna Ogrin; B Catharine Craven; Pamela Houghton
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

Review 7.  Modulation of innate immunity in the tumor microenvironment.

Authors:  Elena Gonzalez-Gugel; Mansi Saxena; Nina Bhardwaj
Journal:  Cancer Immunol Immunother       Date:  2016-06-25       Impact factor: 6.968

Review 8.  Macrophage heterogeneity in atherosclerotic plaques.

Authors:  Jason L Johnson; Andrew C Newby
Journal:  Curr Opin Lipidol       Date:  2009-10       Impact factor: 4.776

9.  Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.

Authors:  Suyang Li; Ying Wu; Sheila M Keating; Hongyan Du; Christina L Sammet; Cindy Zadikoff; Riti Mahadevia; Leon G Epstein; Ann B Ragin
Journal:  J Neurovirol       Date:  2013-08-27       Impact factor: 2.643

10.  1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.

Authors:  Anna Coussens; Peter M Timms; Barbara J Boucher; Timothy R Venton; Anthony T Ashcroft; Keira H Skolimowska; Sandra M Newton; Katalin A Wilkinson; Robert N Davidson; Christopher J Griffiths; Robert J Wilkinson; Adrian R Martineau
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.